BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥8 | ¥5 | ¥4 | ¥4 |
| - Cash | ¥1 | ¥1 | ¥1 | ¥1 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥7 | ¥4 | ¥3 | ¥3 |
| Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| % Growth | -100% | -96.8% | 3,063.6% | – |
| Gross Profit | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | – | 75.8% | 99% | 75.8% |
| EBITDA | -¥0 | -¥0 | -¥0 | -¥0 |
| % Margin | – | -731,103% | -32,144.5% | -835,978.8% |
| Net Income | -¥0 | -¥0 | -¥0 | -¥0 |
| % Margin | – | -732,936.4% | -32,190% | -837,421.2% |
| EPS Diluted | -1.98 | -2.59 | -3.82 | -3.19 |
| % Growth | 23.6% | 32.2% | -19.7% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |